Proportional valve technology in process automation offers a great a deal of flexibility and produces high-quality control results.
According to over 200 life sciences companies surveyed, the number one challenge in speeding products from R&D to patients is quality management, which may surprise many executives that have spent the past decade focused on other issues like validation, regulatory, or supply chain.
Based out of South Boston, MA, with additional research programs in the UK and Canada, Vertex Pharmaceuticals has spent the past 25 years working to improve the lives of patients with serious diseases.
This article takes an in-depth look at how lipid-based drug delivery systems can be used as a bioavailability enhancing technology, as well as the softgel dosage form for their delivery.
As science-based organizations look to leverage the internet of things (IoT) within the laboratory, careful consideration must be given to available technologies, data formats, and platforms.
Fed-batch culture is the commonly adopted biologicals manufacturing method used in many biopharmaceutical companies as it can generate gram/litre amounts of protein-based therapeutics. However, to obtain the maximum production of therapeutic proteins requires the optimum formulation of culture media and feeds, as well as the correct bioprocess parameters.
Good news for plant and animal breeders and molecular biologists in general with the new oKtopure™ from LGC, the fully-automatic extraction of DNA becomes almost as easy as child's play. This DNA extraction robot combines high sample throughput numbers with high-quality standardized DNA purification and thus relieves highly-qualified personnel of the need to carry out routine activities. Part of the solution is a handling system based on electric axes, motors and controllers from Festo.
How an agnostic and data-driven approach early on can optimize the development pathway to bring the molecule to the market faster.
McKesson Medical-Surgical Inc., an affiliate of the McKesson Corporation, has signed an exclusive agreement with bioMérieux, Inc. to serve the U.S. community hospital market